Title |
Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides
|
---|---|
Published in |
Pediatric Nephrology, October 2016
|
DOI | 10.1007/s00467-016-3450-1 |
Pubmed ID | |
Authors |
Lorraine Lau, Zubaida Al-Ismaili, Maya Harel-Sterling, Michael Pizzi, Jillian S. Caldwell, Melissa Piccioni, Larry C. Lands, Theresa Mottes, Prasad Devarajan, Stuart L. Goldstein, Michael R. Bennett, Michael Zappitelli |
Abstract |
Serum cystatin C (CysC) is a more accurate glomerular filtration rate marker than serum creatinine (SCr) and may rise more quickly with acute kidney injury (AKI). We performed a prospective cohort study of 81 non-critically ill children during 110 aminoglycoside (AG) treatments. We calculated area under the curve (AUC) for CysC to diagnose SCr-defined AKI and predict persistent AKI. SCr-AKI definition was based on the Kidney Disease: Improving Global Outcomes (≥stage 1: ≥50 % or 26.5 μmol/l SCr rise from baseline; stage 2: SCr doubling); CysC-AKI was based on a modified version using CysC rise. SCr-AKI and CysC-AKI developed in 45 and 48 % treatments, respectively. CysC rise predicted stage 1 (AUC = 0.75, 95 % CI 0.60-0.90) and 2 (AUC = 0.85, 95 % CI 0.75-0.95) SCr-AKI 2 days before SCr-AKI attainment. The best combined sensitivity/specificity for percent CysC rise to predict stage 1 SCr-AKI was with a 44 % CysC rise (sensitivity = 65 %, specificity = 83 %). CysC rise on day of SCr-AKI development was associated with SCr-AKI ≥48 h (AUC = 0.73, 95 % CI 0.56-0.90) and ≥50 % persistent SCr rise at treatment end (AUC = 0.76, 95 % CI 0.61-0.90). CysC is as an early AKI biomarker and predictive of persistent AKI on aminoglycoside treatment. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 48 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 7 | 15% |
Student > Postgraduate | 7 | 15% |
Student > Master | 5 | 10% |
Researcher | 4 | 8% |
Student > Doctoral Student | 3 | 6% |
Other | 10 | 21% |
Unknown | 12 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 42% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 10% |
Nursing and Health Professions | 3 | 6% |
Engineering | 2 | 4% |
Agricultural and Biological Sciences | 1 | 2% |
Other | 3 | 6% |
Unknown | 14 | 29% |